Connecticut Lawmakers Remove THC Limits on Cannabis Products
Connecticut cannabis THC regulation has changed with the removal of THC limits on products. This allows clinicians to recommend dosing based on patient needs rather than arbitrary caps. The policy shift supports individualized therapeutic approaches.
Applying AI and Machine Learning to Medical Cannabis with Hemant Kumar Bid, PhD
AI cannabis dosing algorithms offer promising advances in medical treatment by improving dosing precision and treatment selection. These tools aim to address challenges in standardizing cannabis protocols. However, clinical validation remains essential…
Does CBD Help with Anxiety? Benefits, Research & What to Expect (2026) – GGG
CBD anxiolytic effects are gaining attention in anxiety research. Current studies suggest CBD may reduce anxiety symptoms through serotonin and GABA pathways. Understanding dosing and interactions is key for safe use.
Cannabis Health Studies Lag Behind Product Development, UMass Researchers Say – NEPM
The cannabis research gap highlights the disconnect between rapid product development and slower clinical studies. This gap affects patient safety and therapeutic outcomes. Clinicians face challenges making evidence-based recommendations due to limited…
House Passes Bill Raising THC Limits: Clinical Implications
Cannabis THC potency regulation is evolving with Connecticut's new bill raising THC limits. This change impacts patient safety and clinical outcomes significantly. Clinicians must understand these regulations to guide dosing and product selection…
Colorado Lawmakers Propose Overhaul of Cannabis Lab Testing
Colorado lawmakers are proposing cannabis lab testing reform to standardize procedures and improve patient safety. This reform aims to address inconsistencies in testing protocols across laboratories. Reliable cannabis lab testing is essential for dosing…
On 4/20, Connecticut Lawmakers Pass Bill Allowing More Potent Cannabis – CT Insider
Connecticut cannabis legislation has passed a bill allowing higher potency cannabis products. This change affects patient access and clinical dosing strategies. Clinicians must update safety protocols to accommodate these new regulations.
Wana CBD Gummies vs. Clinical Doses: Why Your $80 Bottle Isn’t Touching Your Anxiety
CBD dosing anxiety is a critical factor in treatment efficacy. Many retail CBD products offer doses far below clinical thresholds, leading to poor results. Understanding this gap helps patients and clinicians optimize anxiety management.
House Passes Bill Removing Limits on THC in Cannabis Products – CT Mirror
Connecticut THC cannabis regulation has shifted with the removal of potency limits. This change affects patient safety and dosing predictability. Clinicians must adapt to higher potency products in the market.
Monday Health Report: Measuring Cannabis in Units Could Help Identify Risk in Young People
Standardized cannabis dosing units provide clinicians a precise framework for assessing adolescent cannabis consumption patterns and associated risks. This approach improves the accuracy of THC exposure measurement compared to traditional self-reporting…